Gene News and Research

Latest Gene News and Research

Scientists identify key molecular process driving deadly childhood brain cancer

An international group of scientists has identified a key molecular process that drives a deadly form of childhood brain cancer, potentially offering a much-needed, new therapeutic target.

21 May 2025

Discovery of novel gene candidate sheds light on autism mechanisms

Autism spectrum disorder (ASD) is a condition affecting the brain's development and often affects the ability of a person to perceive sensory information and social cues and socialize with others.

21 May 2025

New CRISPR technology delivers RNA precisely to repair damaged brain cells

When a neuron in our body gets damaged, segments of RNA produce proteins that can help repair the injury.

21 May 2025

New genetic mutation linked to increased prostate cancer risk in Ashkenazi Jewish men

Identifying and classifying gene mutations - which are the permanent changes in a person's DNA genetic code - are critical in better understanding, and with research, eventually treating or preventing, the diseases with which they are linked.

21 May 2025

Researchers discover a genetic link to long COVID

An international team of researchers has found a genetic link to long-term symptoms after COVID-19.

21 May 2025

Study explains why some AML patients do not respond to standard treatment

An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone.

21 May 2025

UArizona researchers uncover new way to ease postoperative pain in women

University of Arizona Health Sciences researchers identified a potential way to reduce female post-operative pain by inhibiting pituitary prolactin generated by pre-operative stress.

20 May 2025

New Alzheimer's drug candidate reduces toxic protein and improves memory in mice models

As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the disease and improved memory in mice by boosting production of a protective protein.

20 May 2025

Gut bacteria and genes jointly shape obesity risk, review reveals hidden links

Researchers examined the heritability of body mass index (BMI), highlighting that genetics and the gut microbiome both play major roles in obesity risk. The review emphasizes that maternal microbiome transmission and family environment may help explain “missing heritability” beyond known genetic factors.

20 May 2025

Eating kombu daily enhances gut health and heart markers in men

A 12-week randomized trial found that daily intake of boiled kombu (Laminaria japonica) powder reduced body fat and raised adiponectin in Japanese men, while improving blood pressure and gut microbiota in both sexes. No significant effects were seen in women for body fat reduction or adiponectin.

20 May 2025

Air pollution exposure in pregnancy may increase asthma risk for the next generation

A mother's exposure to air pollution during pregnancy can increase asthma risk in her adult offspring, according to a new mouse study published at the ATS 2025 International Conference.

20 May 2025

Finnish researchers uncover how to optimize bexmarilimab use in cancer care

Researchers at the University of Turku, Finland, have taken a step towards more personalized and effective cancer treatments.

20 May 2025

Personalized gene editing corrects fatal infant metabolic disorder in world-first treatment

Researchers have used a personalised base-editing gene therapy to successfully treat an infant with carbamoyl-phosphate synthetase 1 (CPS1) deficiency, a rare and life-threatening inborn error of metabolism. This pioneering approach chemically corrects the underlying mutation without cutting DNA, showing promise for precision treatment of ultrarare genetic disorders.

20 May 2025

Genetic variations in Prader-Willi syndrome offer key insights into autism and psychosis

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized cutting-edge findings on Prader-Willi syndrome (PWS), revealing how this complex neurodevelopmental disorder serves as a critical model for understanding the interplay between autism spectrum disorder (ASD) and psychotic spectrum disorders (PSD).

20 May 2025

Combination of two drugs shows promise in treating B-cell acute lymphoblastic leukemia

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the commonest cancer in childhood and one that can be particularly difficult to treat in older patients, according to Cambridge scientists.

20 May 2025

MIT researchers discover new potential drug targets for Alzheimer’s disease

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

20 May 2025

Discovery reveals how neuronal ion channels store molecular memory

Researchers have discovered how an ion channel in the brain's neurons has a kind of 'molecular memory', which contributes to the formation and preservation of lifelong memories.

19 May 2025

Study reveals how PAX3 protein drives melanoma growth

PAX3 is a transcription factor (proteins involved in converting DNA into RNA) that drives melanoma progression by promoting cell growth, migration and survival, while inhibiting cellular terminal differentiation, which is the final stage where a cell becomes specialized and cell division ends.

19 May 2025

Study uncovers common trigger across gene mutations that cause ALS

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK DRI) at King's College London have managed to identify a common denominator for different gene mutations that all cause the neurological disease ALS.

19 May 2025

EMA designates allopurinol as first orphan drug for the treatment of Marfan syndrome

The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date.

19 May 2025

Previous
1
...
5
6
7
8
9
10
11
...
1923
Next

Gene News and Research

Latest Gene News and Research

Scientists identify key molecular process driving deadly childhood brain cancer

Discovery of novel gene candidate sheds light on autism mechanisms

New CRISPR technology delivers RNA precisely to repair damaged brain cells

New genetic mutation linked to increased prostate cancer risk in Ashkenazi Jewish men

Researchers discover a genetic link to long COVID

Study explains why some AML patients do not respond to standard treatment

UArizona researchers uncover new way to ease postoperative pain in women

New Alzheimer's drug candidate reduces toxic protein and improves memory in mice models

Gut bacteria and genes jointly shape obesity risk, review reveals hidden links

Eating kombu daily enhances gut health and heart markers in men

Air pollution exposure in pregnancy may increase asthma risk for the next generation

Finnish researchers uncover how to optimize bexmarilimab use in cancer care

Personalized gene editing corrects fatal infant metabolic disorder in world-first treatment

Genetic variations in Prader-Willi syndrome offer key insights into autism and psychosis

Combination of two drugs shows promise in treating B-cell acute lymphoblastic leukemia

MIT researchers discover new potential drug targets for Alzheimer’s disease

Discovery reveals how neuronal ion channels store molecular memory

Study reveals how PAX3 protein drives melanoma growth

Study uncovers common trigger across gene mutations that cause ALS

EMA designates allopurinol as first orphan drug for the treatment of Marfan syndrome

eBook: Using iPSCs models for human disease research and drug discovery eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?